PC4 Potentially Predicts Chemoradiation‐Induced Antitumor Immunity in Esophageal Squamous Cell Carcinoma

Documenti analoghi

• Therapeutic Effect of Lymph Node Dissection After Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy on Esophageal Squamous Cell Carcinoma Using the Efficacy Index
  di: Jiyoun Park, et al.
  Pubblicazione: (2025)
• Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma
  di: Yafan Yang, et al.
  Pubblicazione: (2025)
• Application of Esophageal Sponge Cytology in Screening Esophageal Squamous Cell Carcinoma in a High‐Risk Region of China
  di: Shu Huang, et al.
  Pubblicazione: (2025)
• Impacts of Mitochondrial Status After Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma Patients
  di: Kotaro Sugawara, et al.
  Pubblicazione: (2025)
• Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma
  di: Changyu Zhu, et al.
  Pubblicazione: (2025)